Bivacor Total Artificial Heart Implanted in Five Patients
BiVACOR, a clinical-stage medical device company, has successfully completed the initial phase of its FDA Early Feasibility Study (EFS)...
Insitro Achieves $25M Milestone for ALS Genetic Target Discovery
Insitro, a machine learning-driven drug discovery company, achieved a milestone in its collaboration with Bristol Myers Squibb, receiving $25...
Holoclara Initiates Phase 1 HC002 Trial in Adults
Holoclara, a biotechnology company, has launched its first-in-human Phase 1 clinical trial for HC002, an orally available small molecule...
Benchstrength Secures $62M Early-Stage Venture Capital Fund
Benchstrength, a New York City-based venture capital firm, has closed its first fund with investments from prominent institutions like...
CardioFocus Treats First Patients with Pulsed Field Ablation
CardioFocus, Inc. has initiated the VISION AF clinical trial, marking the first use of its investigational OptiShot™ Pulsed Field...
Protein Helps Cancer Evade CAR T-Cell Therapy
Scientists at City of Hope have identified a protein, YTHDF2, that helps blood cancer cells evade CAR T cell...
eClinical Solutions and Snowflake Partner for Life Sciences
eClinical Solutions and Snowflake have partnered to integrate eClinical’s elluminate Clinical Data Cloud with the Snowflake AI Data Cloud....
Silexion’s Precision Oncology Collaboration: Targeting KRAS
Silexion Therapeutics is developing SIL-204, a next-generation siRNA therapy targeting a broad range of KRAS mutations prevalent in difficult-to-treat...
Fresenius Kabi Launches Epinephrine Injection, Expands US Pharma Portfolio
Fresenius Kabi has launched Epinephrine Injection, USP, the first generic version of epinephrine in a 1mg/1mL vial, in the...
Trodelvy Gets Breakthrough Therapy for Lung Cancer
The FDA has granted Breakthrough Therapy Designation to Gilead Sciences’ Trodelvy for treating extensive-stage small cell lung cancerlung cancer...